000 01479 a2200397 4500
005 20250511180245.0
264 0 _c19920910
008 199209s 0 0 eng d
022 _a0002-9378
024 7 _a10.1016/s0002-9378(11)91435-5
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSutton, G P
245 0 0 _aIfosfamide alone and in combination in the treatment of refractory malignant gestational trophoblastic disease.
_h[electronic resource]
260 _bAmerican journal of obstetrics and gynecology
_cAug 1992
300 _a489-95 p.
_bdigital
500 _aPublication Type: Case Reports; Clinical Trial; Journal Article; Multicenter Study
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xtherapeutic use
650 0 4 _aChoriocarcinoma
_xdrug therapy
650 0 4 _aCisplatin
_xtherapeutic use
650 0 4 _aEtoposide
_xtherapeutic use
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aIfosfamide
_xadministration & dosage
650 0 4 _aMiddle Aged
650 0 4 _aPregnancy
650 0 4 _aPregnancy Complications, Neoplastic
650 0 4 _aTrophoblastic Neoplasms
_xdrug therapy
700 1 _aSoper, J T
700 1 _aBlessing, J A
700 1 _aHatch, K D
700 1 _aBarnhill, D R
773 0 _tAmerican journal of obstetrics and gynecology
_gvol. 167
_gno. 2
_gp. 489-95
856 4 0 _uhttps://doi.org/10.1016/s0002-9378(11)91435-5
_zAvailable from publisher's website
999 _c1329736
_d1329736